Display options
Share it on

J Dtsch Dermatol Ges. 2021 Jul;19:11-13. doi: 10.1111/ddg.14472.

Therapieresistente Pityriasis rubra pilaris erfolgreich therapiert mit Adalimumab.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Ana Luiza Lima, Franziska Pahnke, Sibylle Schliemann, Jörg Tittelbach, Peter Elsner

Affiliations

  1. Klinik für Hautkrankheiten des Universitätsklinikums Jena.

PMID: 33835655 DOI: 10.1111/ddg.14472

[No abstract available.]

References

  1. Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol 2010; 11(3): 157-170. - PubMed
  2. Moretta G, De Luca EV, Di Stefani A. Management of refractory pityriasis rubra pilaris: challenges and solutions. Clin Cosmet Investig Dermatol 2017; 10: 451-457. - PubMed
  3. Engelmann C, Elsner P, Miguel D. Treatment of pityriasis rubra pilaris type I: a systematic review. Eur J Dermatol 2019; 29(5): 524-37. - PubMed
  4. Usuki K, Sekiyama M, Shimada T, Shimada S, Kanzaki T. Three cases of pityriasis rubra pilaris successfully treated with cyclosporin A. Dermatology 2000; 200: 324-7. - PubMed
  5. Eastham AB, Femia AN, Qureshi A, Vleugels RA. Treatment options for pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center. JAMA Dermatol 2014; 150: 92-4. - PubMed
  6. Petrof G, Almaani N, Archer CB, Griffths WA, Smith CH. A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists. J Eur Acad Dermatol Venereol. 2013; 27(1): 131-135. - PubMed

Publication Types